DBVT · DBV Technologies S.A.
$13.79
-0.45 (-3.16%)
At close · Aug 6
Market Cap
$4.22B
Shares
296.06M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$14.24
Open$13.87
Day$13.84–14.58
52W$8.70–26.19
Avg vol 30d320K
Short int1.5M · 0.5% float · 7.8d
Short vol47%
Last earningsJul 16, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 16
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 16, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.46
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−22%
below
Price vs 50-day avg
−10%
below
RSI (14)
44
neutral
MACD trend
Positive
52-week position
32%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−15%
trailing
6-month return
−37%
trailing
YTD return
−26%
this year
Relative strength
−48%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $16 › 200d $18 — 200d above 50d
Institutional flow
Distributing
16 of 72 funds reported for Jun 30 · net -41.7K sh shares · +2 new
Insider flow
Distributing
Net -$1.3K over 90 days · 100% sells
Short interest
Rising
0.50% of float · ▲ +13.2% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
72 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+36%
Y/Y
EPS growth
+10%
Y/Y
Free cash flow
$-121.7M
Balance sheet
$192.7M
net cash
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−45%
past year
ATR
5.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−22%
Bearish
Price vs 50-day avg
−10%
Bearish
RSI (14)
44
Neutral
MACD trend
Positive
Bullish
52-week position
32%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $16 › 200d $18 — 200d above 50d
Institutional flow
Distributing
16 of 72 funds reported for Jun 30 · net -41.7K sh shares · +2 new
Insider flow
Distributing
Net -$1.3K over 90 days · 100% sells
Short interest
Rising
0.50% of float · ▲ +13.2% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
72 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $9
Now $14 · 32%
52-wk high $26
vs 200-day avg -22%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DBVT
this stock
DBV Technologies S.A.
|
$4.22B | -25.7% | +35.8% | — | 0.5% |
|
ONC
BeOne Medicines Ltd.
|
$484.13B | +7.8% | +22179.2% | 744.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.89B | +6.9% | +46.2% | 28.2 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.13B | -0.2% | +20.8% | 19.0 | 3.4% |
|
ARGX
Argenx SE
|
$54.30B | +3.2% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DBVT | +3.7% | -15.0% | -37.0% | +5.5% | -25.7% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -1.8% | -18.3% | -48.2% | +2.4% | -38.6% |
Key facts
CIK
1613780
CUSIP
23306J309
13F (30d)
14 filings
14 filers
Visit website
Investor relations